Bitopertin
disc
[]
in data presented at #eha2023, disc announced initial positive results from beacon, our phase 2 clinical trial for bitopertin in #epp. read more: 
Disc Medicine is applying new insights in heme biosynthesis and iron metabolism to develop first-in-class therapies for #hematologic diseases.